Containment Considerations for the Cryopreservation of Cell and Gene Therapies

Containment Considerations for the Cryopreservation of Cell and Gene Therapies

07/15/2020, 11:15 AM - 12:00 PM

Stage 3, Booth 1877, Exhibit Hall
The commercialization of cells and nucleic acids for therapeutic use drives a critical need for the refinement of containment and storage procedures to ensure drug product integrity is maintained until administration to the patient. Development of these advanced therapies often begins in an academic setting and is then translated through the clinic into a product ready for GMP manufacture. Along with the product, minimally-controlled processes using research grade consumables are also transferred and are often not revisited until most drug product characterization has been completed. This can give rise to costly changes later, as product handling and storage can have a direct impact on its quality characteristics. On this journey from bench to bedside it is vital that the processes and equipment used are similarly translated to meet the needs of a therapeutic. Here, we identify aspects of containment and storage that can aid in development of advanced therapies if considered early.


  • Crystal Kraft, PhD


    Senior Scientific Lead, Advanced Therapies

    West Pharmaceutical Services


  1. Objective 1. Articulate fundamental differences between cell and nucleic acid handling and storage processes in academic and therapeutic applications. 2. Identify critical elements of advanced therapy containment and storage with supporting examples and data. 3. Advise on practices that can be adopted early on in advanced therapy development that could help to mitigate risk later.

Type of Session

  1. Type of Session


  1. Track

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.